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A n   oral  adm inistration  of  fungal  polysaccharid e
schizophyllan  has  augm ented  protective  im m une  re-
sponses to Sendai virus infection in m ice and the rod-
shaped DNA virus of Penaeus japonicus (RV-PJ) infec-
tion in Kurum a shrimps. W hen schizophyllan was ad-
m inistered orally  at  a dose of  50  or 100  m g/kg body
weight per day, the survival rates after virus challenge
were  significantly  higher  than  those  of  the  control
groups. High phagocytic activities were observed in the
haem ocytes of the schizophyllan-fed shrim ps. These re-
sults suggest that schizophyllan confers effective pro-
tection against viral infection by increasing antiviral im-
mune responses, and that it could be used to boost im -
munity  to  virus  infection  in  anim als  or  in  inverte-
brates.
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Introduction
Schizophyllan is a water-soluble, non-ionic polysac-
charide produced extracellularly by the fungus Schiz-
ophyllum commune Fries. It consists of a main chain
of (1® 3)-b -D-glucose residues substituted at 0±6 by
a single-unit b -D-glucosyl residue, with a side chain
of  a b -1,6-D-glucosyl  group  at  every  three  glucose
residues of the main chain [1]. Schizophyllan has anti-
tumor and antimicrobial activities, mediated by stim -
ulation  of  the  host  imm une  system s  [2,3].  Schizo-
phyllan  is  well  known  in  Japan  as  a  biological  re-
sponse modifier in clinical use [4].
It  has  been  reported  that  schizophyllan  activates
host-defense systems such  as macrophages,  natural
killer cells, antibody-dependent cellular cytotoxicity
and cytotoxic T  lymphocytes. These immune systems
also provide an important level of protection against
viral  infection  [5,6].  Therefore,  schizophyllan  has
potential use as an agent to increase protective im -
munity against viral infection.
Recently,  infectious  viral  diseases  have  occurred
frequently worldwide in culture farms of som e ani-
mals, fishes and shrim ps. In Japan, a new acute viral
disease was identified in 1993 at  shrimp farms and
has caused severe losses to shrim p farmers. The caus-
ative agent was a rod-shaped DNA virus of Penaeus
japonicus (RV-PJ) [7].
Here we present data on the oral administration of
schizophyllan and the imm une responses to Sendai
virus infection in mice and RV-PJ infection in shrim ps.
Materials and methods
Schizophyllan
Schizophyllan with a molecular weight of 4.6 ´ 10
5
was used for the Sendai virus challenge test, and crude
schizophyllan for the shrim p test. Crude schizophyl-
lan is a dried culture broth of the schizophyllan-pro-
ducing fungus  Schizophyllum comm une  Fries. Both
substances  were  m anufactured  by  Taito  Co.,  L td
(Kobe, Japan).
Sendai virus challenge test in mice
Specific-pathogen-free, 3-w eek-old male Institute of
Cancer Research/Charles River Japan Inc. (ICR/CRJ;
CD-1) mice were  treated  orally with schizophyllan
(100 mg/kg body weight per day) by a feeding tube
for 5 days.  Control mice were  given the same vol-
ume of phosphate-buffered saline instead of schizo-
phyllan. The mice were inoculated intranasally with
4.0 ´ 10
6 cell infectious units (10 times the median
lethal dose, LD 50) of the Fushim i strain of the Sendai
virus. After virus inoculation, the m ice were further
treated with schizophyllan for an additional 2 days.
The protective effects of schizophyllan were assessed
on the basis of survival ratios for the test mice [8]. A
protocol of the test is shown in Fig. 1.
RV-PJ challenge test in shrimps
Two groups of Kuruma shrimps  (10±20 g), with 30
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crude schizophyllan/kg body w eight/day in their diet
for 7 days. Then the shrimps were challenged by in-
tramuscular  injection  with  0.1 ml  extracted  filtrate
from lymphoid tissues of diseased shrimps.
Phagocytic activity
Hemocytes were obtained from the hearts of shrim ps.
The  hem ocytes  (1 ´ 10
5  cells/ml)  were  mixed  with
fluorescence-labeled  latex  beads  (1 ´ 10
8 beads/ml)
in K199 medium  [9]. After incubation at 25Ê C for 30
min,  the  num ber  of  ingested  beads  and  number  of
phagocytizing cells were counted from any 200 cells
observed.  T he  phagocytic  index  was  calculated as:
(no. of cells ingesting beads/no. of cells observed) ´
(no. of beads ingested/no. of cells observed) ´ 100.
Results
Protection of mice by schizophyllan against Sendai
virus infection
Fig.  2  shows  that  50%   of  m ice  treated  orally  with
schizophyllan survived the viral pneumonia. The sur-
vival ratio was significantly higher than that of con-
FIG. 2. Protective effect of schizophyllan (S) against Sendai virus
infection in mice. C, control.
trol mice.  The efficacy of the oral administration of
schizophyllan was almost equal to that of intraperi-
toneal  injection.
Protection of shrimps by crude schizophyllan against
RV-PJ infection
Fig. 3 shows changes in survival rates after a virus
challenge in shrimps given food with or without crude
schizophyllan.  The final survival rates were 37%  in
crude schizophyllan-fed shrimps and 10%  in controls.
These results demonstrate that an oral administration
of  crude schizophyllan increases the disease-resist-
ance of shrimps against RV-PJ infection 4±9 days af-
ter adm inistration.
Phagocytic activity
Fig.  4  shows the  changes  in phagocytic activity  of
shrimp hemocyte when crude schizophyllan was ad-
m inistered  orally.  The  phagocytic  activity  of  the
crude  schizophyllan-fed  shrimps  was  significantly
higher than that of controls (P < 0.05). These results
indicate that shrim p hemocytes are activated by the
oral administration of crude schizophyllan.
Conclusions
One basic and im portant strategy to prevent virus in-
fectious diseases is to increase the protective im mune
responses of a host.  The results outlined here show
FIG. 3. Protective effect of an oral administration (50 mg/kg body
weight per day) of schizophyllan against infection by the rod-
shaped  DNA  virus  of  Penaeus  japonicus  (RV-PJ)  in  Kuruma
shrimps.
FIG. 1. Protocol of Sendai virus-challenge test.Oral administration of schizophyllan
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that an oral dose of schizophyllan induces a protec-
tive immune response against virus infection in mice
and against RV-PJ infection in shrim ps. Thus schizo-
phyllan may have potential as an immune enhancer
against viral infection in anim als or in invertebrates.
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FIG. 4. Increase in phagocytic activity by shrimp hemocytes after
an oral administration of schizophyllan.